SCHEMBL2494201

SCHEMBL2494201

Cc1cc(C)c(N2c3ccccc3S(=O)(=O)c3cc(/C=C/c4ccc(-c5ccc(/C=C/c6ccc7c(c6)S(=O)(=O)c6ccccc6N7c6c(C)cc(C)cc6C)cc5)cc4)ccc32)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAOA P21397 1/20 0.34
NR1H3 Q13133 1/20 0.32
RXFP1 Q9HBX9 1/20 0.31
ALOX5 P09917 2/20 0.30
PTGS1 P23219 2/20 0.30
PTGS2 P35354 2/20 0.30
TTR P02766 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494203 1.00 MAPT (0.36) MAPTPOLBLMNATP53MAOA
SCHEMBL2500050 0.86 ALDH1A3 (0.40) MAPTPOLBLMNATP53MAOA
SCHEMBL2500153 0.83 LMNA (0.47) MAPTPOLBLMNATP53MAOA
SCHEMBL13022534 0.82 LMNA (0.46) MAPTPOLBLMNATP53MAOA
SCHEMBL2498560 0.81 RXFP1 (0.37) MAPTPOLBLMNATP53MAOA
SCHEMBL2498562 0.81 RXFP1 (0.37) MAPTPOLBLMNATP53MAOA
SCHEMBL2500070 0.81 MAOA (0.51) MAPTPOLBLMNATP53MAOA
SCHEMBL2500073 0.81 MAOA (0.51) MAPTPOLBLMNATP53MAOA
SCHEMBL13021729 0.74 NPSR1 (0.39) MAPTLMNATP53MAOA
SCHEMBL13022537 0.73 LMNA (0.42) MAPTPOLBLMNATP53MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817806-B1 PHENOTHAZINES-S-OXIDES AND S,S-DIOXIDES AS hole and excitonblockers for OLEDs BASF SE (DE) 2014-07-30 EP disclosed
US-8029919-B2 Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs BASF AKTIENGESELLSCHAFT (DE) 2011-10-04 US disclosed
US-8029919-B2 Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs BASF AKTIENGESELLSCHAFT (DE) 2011-10-04 US disclosed
US-8029919-B2 Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs BASF AKTIENGESELLSCHAFT (DE) 2011-10-04 US disclosed
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds BASF AKTIENGESELLSCHAFT (DE) 2010-12-09 US disclosed
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds BASF AKTIENGESELLSCHAFT (DE) 2010-12-09 US disclosed
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds BASF AKTIENGESELLSCHAFT (DE) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds PPOX, SMOX, SORD MAPT 218/4885POLB 526/4885LMNA 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.